← Association for Accessible Medicines
FDANonrulemakingFDA-2018-N-2689

Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments

RIN
—
Last modified
Feb 25, 2019
Comment window
closed 2867d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Sep 26, 2018 and Sep 26, 2018. 1 other organizations filed here. The comment window closed 2867d ago.

What Association for Accessible Medicines filed (1)

Sep 26, 2018· Comment from Association for Accessible Medicines (AAM) and Biosimilars Council· FDA-2018-N-2689-0078

Comments from The Association for Accessible Medicines (AAM) and the Biosimilars Council on behalf of our member companies, regarding Docket FDA-2018-N-2689, Facilitating Competition and Innovation in the Biological Products Marketplace, Public Hearing; Request for Comments.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (1)

See everyone who commented →
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments (FDA) — Association for Accessible Medicines | OpenPolis